Health organizations target Florida medicaid transgender rule
Health care organizations are seeking to bolster a legal challenge to a new Florida rule that prevents Medicaid from paying for treatments such as puberty blockers and hormone therapy for transgender people. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 28, 2022 Category: Biotechnology Authors: Jim Saunders Source Type: news
Hormonal Breast Cancer Therapy May Work Differently, Depending on Patient's Race
FRIDAY, Sept. 16, 2022 -- For women with breast cancer, their race may help predict the success of hormone therapy given before surgery.
In a new study, researchers found that Black women treated with hormone therapy before cancer surgery (so-called... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 16, 2022 Category: General Medicine Source Type: news
Low Testosterone Levels Tied to More Severe COVID in Men
MONDAY, Sept. 5, 2022 -- Men with low testosterone levels may be more likely to have more severe illness when infected with COVID-19, according to a new study.
Treating men who have low testosterone with hormone therapy may reduce their risk of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 5, 2022 Category: General Medicine Source Type: news
Discrimination and psychopathology in gender dysphoria: a hormone therapy - Shirdel Havar E, Stoet G.
PURPOSE: One of the strategies for treating gender dysphoria is cross-sex hormone therapy (CHT). Our study aimed to explore the differences in the psychopathology of people with gender dysphoria who received the hormone with those who did not this treatmen... (Source: SafetyLit)
Source: SafetyLit - September 5, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Hormone therapy may boost brain function for people with Down ’s syndrome, study finds
Men given a dose of gonadotropin-releasing hormone every two hours showed improvements in cognitive function in small-scale trialRegular doses of a hormone may help to boost cognitive skills in people with Down ’s syndrome, a pilot study has suggested.Researchers fitted seven men who have Down ’s syndrome with a pump that provided a dose of GnRH, a gonadotropin-releasing hormone, every two hours for six months.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 1, 2022 Category: Science Authors: Nicola Davis Tags: Down's syndrome Health Medical research Science Source Type: news
Impact of Gender-Affirming Hormone Therapy on Kidney Function Examined
WEDNESDAY, Aug. 17, 2022 -- Gender-affirming hormone therapy (GAHT) is associated with increased serum creatinine in transgender men, but not in transgender women, according to a systematic review and meta-analysis published online Aug. 16 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 17, 2022 Category: Pharmaceuticals Source Type: news
NAMS Affirms Value of Hormone Therapy for Menopausal Women NAMS Affirms Value of Hormone Therapy for Menopausal Women
Recent research supports individualized care to maximize benefits and minimize risks.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - August 8, 2022 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Injectable HIV Prevention Better Than Pills in Two Trials Injectable HIV Prevention Better Than Pills in Two Trials
One trial confirmed the efficacy of CAB LA for transgender women who were also receiving gender-affirming hormone therapy.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - August 3, 2022 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Hormone Therapy Not Tied to Breast Cancer Recurrence, Mortality
No increased risk seen for women using either vaginal estrogen therapy or menopausal hormone therapy after diagnosis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 29, 2022 Category: Cancer & Oncology Tags: Gynecology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news
Hormone Therapy Not Tied to Breast Cancer Recurrence, Mortality
FRIDAY, July 29, 2022 -- In postmenopausal women treated for early-stage estrogen receptor-positive breast cancer, neither vaginal estrogen therapy (VET) nor menopausal hormone therapy (MHT) is associated with an increased risk for recurrence or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2022 Category: Pharmaceuticals Source Type: news
Prostate Cancer Treatment May Raise Heart Risks
WEDNESDAY, July 27, 2022 -- Hormone therapy is a common treatment option for prostate cancer, but it may increase the risk of death from heart disease, especially in older men, a new study finds.
Dr. William Dahut, a prostate cancer researcher and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 27, 2022 Category: General Medicine Source Type: news
Hormone Therapy Risk in Postmenopausal ER+ Breast Cancer Hormone Therapy Risk in Postmenopausal ER+ Breast Cancer
Hormone therapy did not increase mortality in postmenopausal women treated for early-stage estrogen receptor –positive breast cancer, but there was a recurrence risk with vaginal estrogen therapy.MDedge News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - July 22, 2022 Category: OBGYN Tags: Hematology-Oncology News Source Type: news
Rising Gestational Diabetes Rates; Updated Hormone Therapy Statement; Insulin Recall
(MedPage Today) -- The U.S. is seeing a rise in gestational diabetes rates, with a 30% jump from 2016 to 2020, the CDC reported.
Among 1,050 U.S. adults ages 45 and older, receiving federal rental assistance through project-based housing was tied... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 21, 2022 Category: Endocrinology Source Type: news
NAMS Updates Position Statement on Menopausal Hormone Therapy
WEDNESDAY, July 20, 2022 -- Hormone therapy remains the most effective treatment for vasomotor symptoms (VMS) and genitourinary syndrome of menopause, according to a position statement issued by the North American Menopause Society (NAMS) and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2022 Category: Pharmaceuticals Source Type: news
Transgender Youth on Hormone Therapy Risk Substantial Bone Loss Transgender Youth on Hormone Therapy Risk Substantial Bone Loss
It appears that bone health deserves attention when adolescents are placed on gender-affirming hormone therapy.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 8, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
